Literature DB >> 13428919

On the concentration of 5-hydroxytryptamine in mammalian enterochromaffin cells and its release by reserpine.

E P BENDITT, R L WONG.   

Abstract

The enterochromaffin cells of the guinea pig duodenum and 5-hydroxytryptamine incorporated into gelatin models gave, after formalin fixation, nearly identical reactions with methenamine silver, ferric-ferricyanide, and diazotized o-aminoazotoluene. Following formaldehyde fixation the indole reaction with p-dimethylaminobenzaldehyde was negative in tissue enterochromaffin cells; similarly the indole reaction was negative after formaldehyde fixation of gelatin models. In the duodenum of the guinea pig 5-hydroxytryptamine appears to be largely, if not entirely, contained in the enterochromaffin cells. Its intracellular concentration estimated from relative cell volume and assay of concentration in the whole tissue, was not less than 5 mg./gm. of cells, and as judged by the intensity of staining reaction may have been as high as 10 to 20 mg./gm. of cells. Reserpine administered parenterally caused release of the chromogenic material of duodenal enterochromaffin cells and a parallel reduction in the amount of extractable 5-hydroxytryptamine.

Entities:  

Keywords:  DUODENUM/metabolism; RESERPINE/effects; SEROTONIN/metabolism

Mesh:

Substances:

Year:  1957        PMID: 13428919      PMCID: PMC2136718          DOI: 10.1084/jem.105.6.509

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  Drugs which antagonize 5-hydroxytryptamine.

Authors:  J H GADDUM; K A HAMEED
Journal:  Br J Pharmacol Chemother       Date:  1954-06

2.  The histamine and serotonin content of the platelets and polymorphonuclear leucocytes of various species.

Authors:  J H HUMPHREY; R JAQUES
Journal:  J Physiol       Date:  1954-05-28       Impact factor: 5.182

3.  Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis; a clinical and pathologic syndrome.

Authors:  A THORSON; G BIORCK; G BJORKMAN; J WALDENSTROM
Journal:  Am Heart J       Date:  1954-06       Impact factor: 4.749

4.  Detection of 5-hydroxytryptamine in mammalian enterochromaffin cells.

Authors:  R BARTER; A G PEARSE
Journal:  Nature       Date:  1953-10-31       Impact factor: 49.962

5.  The variable arterial pressure response to serotonin in laboratory animals and man.

Authors:  I H PAGE; J W MCCUBBIN
Journal:  Circ Res       Date:  1953-07       Impact factor: 17.367

6.  Circulatory effects of 5-hydroxytryptamine.

Authors:  G REID
Journal:  J Physiol       Date:  1952-12       Impact factor: 5.182

7.  Fractionation of the smooth muscle stimulants present in extracts of gastro-intestinal tract. Identification of 5-hydroxytryptamine and its distinction from substance P.

Authors:  C E DALGLIESH; C C TOH; T S WORK
Journal:  J Physiol       Date:  1953-05-28       Impact factor: 5.182

8.  Pharmacology of Rauwolfia alkaloids, including reserpine.

Authors:  A J PLUMMER; A EARL; J A SCHNEIDER; J TRAPOLD; W BARRETT
Journal:  Ann N Y Acad Sci       Date:  1954-04-30       Impact factor: 5.691

9.  Release of 5-hydroxytryptamine (serotonin) from the dog's gastrointestinal tract.

Authors:  C C TOH
Journal:  J Physiol       Date:  1954-11-29       Impact factor: 5.182

10.  Absorption of serotonin (5-hydroxytryptamine) and histamine by dog platelets.

Authors:  J H HUMPHREY; C C TOH
Journal:  J Physiol       Date:  1954-05-28       Impact factor: 5.182

View more
  23 in total

1.  [Model experiments on histochemical silver-reducing substrate].

Authors:  M RATZENHOFER; F LEMBECK
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1959

2.  Serotonin antagonists in experimental and clinical "dumping'.

Authors:  L P JOHNSON; R D SLOOP; J E JESSEPH; H N HARKINS
Journal:  Ann Surg       Date:  1962-10       Impact factor: 12.969

3.  Non-functional bronchial carcinoid tumours.

Authors:  P S VASSAR; C F CULLING
Journal:  Can Med Assoc J       Date:  1962-08-11       Impact factor: 8.262

4.  Tumours of the lung and the carcinoid syndrome.

Authors:  E D WILLIAMS; J G AZZOPARDI
Journal:  Thorax       Date:  1960-03       Impact factor: 9.139

5.  Fluorescent mast cell in precancerous mouse skin.

Authors:  J F RILEY
Journal:  Experientia       Date:  1958-04-15

6.  The effect of diet on the 5-hydroxytryptamine content of the small intestine and other organs in rats and mice.

Authors:  T J Sullivan
Journal:  Br J Pharmacol Chemother       Date:  1960-12

7.  The effect of serotonin on pepsin inhibition by duodenal fat.

Authors:  M F Wazna; T Stein; L Wise
Journal:  Ann Surg       Date:  1977-08       Impact factor: 12.969

8.  The role of pharmacologically-active amines in resistance to Trichostrongylus colubriformis in the guinea-pig.

Authors:  T L Rothwell; J K Dineen; R J Love
Journal:  Immunology       Date:  1971-12       Impact factor: 7.397

9.  [Influence of angiotensin on the argentaffin system of the guinea pig].

Authors:  R Huber; E Weber; C Hedinger
Journal:  Experientia       Date:  1968-02-15

10.  Mechanism of action of reserpine in producing gastric haemorrhage and erosion in the mouse.

Authors:  J G BLACKMAN; D S CAMPION; F N FASTIER
Journal:  Br J Pharmacol Chemother       Date:  1959-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.